Application of Low Doses of Ionizing Radiation in Medical Therapies

Jerry M Cuttler, Jerry M Cuttler

Abstract

The discovery of X-rays and radioactivity in 1895/1896 triggered a flood of studies and applications of radiation in medicine that continues to this day. They started with imaging fractures/organs and progressed to treating diseases by exposing areas to radiation from external and internal sources. By definition, low-dose treatments stimulate damage control (or adaptive protection) systems that remedy diseases. Publications are identified on low-dose ionizing radiation (LDIR) therapies for different cancers, infections, inflammations, and autoimmune and neurodegenerative diseases. The high rate of endogenous DNA damage, due to leakage of oxygen from aerobic metabolism, and the damage control systems that deal with this are discussed. Their stimulation and inhibition by radiation are described. The radium dial painter studies revealed the radium ingestion threshold for malignancy and the dose threshold for bone sarcoma. The radiation scare that misled the medical profession and the public is a barrier to LDIR therapies. Many studies on nasal radium irradiation demonstrated that children are not unduly radiation sensitive. Omissions in the medical textbooks misinform physicians about the effects of LDIR therapy, which blocks clinical trials to determine optimal doses, efficacy, and thresholds for onset of harm. Information from many recent case reports on LDIR therapies, including successes with radon therapy, is provided.

Keywords: autoimmune disease; cancer remediation; inflammation; low-dose ionizing radiation; radiation hormesis; radon therapy.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

© The Author(s) 2020.

Figures

Figure 1.
Figure 1.
Leakage of reactive oxygen species (ROS) from oxygen metabolism and ionizing radiation (IR) effect on DNA and biomolecules.
Figure 2.
Figure 2.
Biphasic dose–response model. Definition of a low dose and a high dose of radiation.
Figure 3.
Figure 3.
Stepwise decrease in annual occupational dose limit from 70 rem (1924) to 5 rem (1958).
Figure 4.
Figure 4.
Standard radium solution for drinking, 2 μg or 2 μCi.
Figure 5.
Figure 5.
Study of 1468 female radium dial painters indicated a 100 μCi systemic intake threshold for malignancies. There were 56 malignancies among the 1468 dial painters in this study.
Figure 6.
Figure 6.
Cumulative incidence of bone sarcoma versus cumulative rad (CR) from radium ingested by dial painters indicates a 10 Gy threshold. Note the plateau at about 30%, from 10 to 500 Gy.
Figure 7.
Figure 7.
Severe hand injury with some gas in tissue (left) and same hand a few days after prophylactic X-ray irradiation (right).
Figure 8.
Figure 8.
Reduction in gas gangrene mortality from 50% to 5% by using X-ray therapy.
Figure 9.
Figure 9.
Child receiving nasal radium irradiation treatment.
Figure 10.
Figure 10.
Position of the 2 radium probes.
Figure 11.
Figure 11.
Low dose of ionizing radiation depresses lung metastases in mice when total body radiation is given 12 days after tumor cell transplantation into groin. Lung colonies were counted 20 days after TBI occurred.
Figure 12.
Figure 12.
Survival of patients with non-Hodgkin lymphoma treated by the combined treatment of low-dose total body radiation (TBI) and high-dose local irradiation (solid line) versus patients treated by high-dose local irradiation alone (dotted line).
Figure 13.
Figure 13.
Survival of patients with non-Hodgkin lymphoma, stage I and II, treated by the combined therapy of low-dose total body radiation (TBI) and high-dose local irradiation (solid line) versus patients treated by the combined therapy of high-dose local irradiation followed by chemotherapy (dashed line).
Figure 14.
Figure 14.
Prostate-specific antigen (PSA) change shows the improvement in the condition of patient with prostate cancer after 30 X-ray treatments of 0.15 Gy each.
Figure 15.
Figure 15.
Prostate-specific antigen (PSA) change shows the improvement in the condition of patient with prostate cancer after 10 X-ray treatments of 0.1 Gy and radon bedsheet therapy each night, for 10 months.
Figure 16.
Figure 16.
Cancer markers show improvement in condition of patient with breast cancer after inhaling radon, 0.5 to 1.0 MBq/m3, for 40 minutes, twice, 3 days per week.
Figure 17.
Figure 17.
Cancer markers show improvement in condition of patient with breast cancer after 40 minutes of hormesis room therapy, twice daily (radon = 9800 Bq/m3; γ-radiation level = 11 μSv/h).
Figure 18.
Figure 18.
Changes in values of 2 markers show the improvement in the condition of a patient with advanced rheumatoid arthritis after receiving hormesis room and radon nebulizer therapies.
Figure 19.
Figure 19.
Cancer markers show improvement in condition of patient with liver cell cancer after the radon concentration was increased 6-fold to 6 MBq/m3 on August 6, 2018.
Figure 20.
Figure 20.
Pemphigus autoimmune disease subsided after patient received hormesis room and radon generator therapies.
Figure 21.
Figure 21.
Author beside patient with Parkinson disease and patient with Alzheimer dementia. Computed tomography scans of brain-stimulated protection against oxidative stress, restoring a degree of cognition, memory, speech, movement, and appetite.-
Figure 22.
Figure 22.
DNA damage control biosystem, showing the effects of the 3 types of natural adaptive protection systems against reactive oxygen species (ROS)-induced damage in human cells.
Figure 23.
Figure 23.
Evidence of a threshold at 1.1 Gy for radiation-induced leukemia from an analysis of the data of 95 819 Hiroshima atomic bomb survivors.,

References

    1. Historical Medical Library of the College of Physicians of Philadelphia. Radium. . Accessed December 11, 2019.
    1. Brucer M. A Chronology of Nuclear Medicine. St Louis, MO: Heritage Publications; 1990.
    1. Rowland RE. Radium in humans: a review of U.S. studies. Washington, DC; 1994. ANL/ER-3, UC-408. DOE.
    1. Sanders CL. Radiation Hormesis and the Linear-No-Threshold Assumption. Berlin, Germany: Springer; 2010.
    1. Sanders CL. Radiobiology and Radiation Hormesis: New Evidence and its Implications for Medicine and Society. Cham, Switzerland: Springer; 2017.
    1. Applications of low radiation doses in medical diagnosis and therapy Paper presented at: Polish Radiation Research Society Symposium; September 17-18, 2019; Kielce, Poland.
    1. Clarke R, Valentin J. A history of the international commission on radiological protection. Health Phys. 2005;88(5):407–422.
    1. Azzam EI, Jay-Gerin J-P, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327(1-2):48–60.
    1. Calabrese EJ. Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Environ Pollut. 2013;182:452–460.
    1. Inkret WC, Meinhold CB, Taschner JC. Radiation and risk—a hard look at the data. Los Alamos Sci. 1995;23:116–123. . Accessed December 11, 2019.
    1. Muller HJ. Artificial transmutation of the gene. Science. 1927;66:84–87.
    1. Muller HJ, Mott-Smith LM. Evidence that natural radioactivity is inadequate to explain the frequency of “natural” mutations. Proc Nat Acad Sci. 1930;16:277–285.
    1. Calabrese EJ. Muller’s Nobel Prize data: getting the dose wrong and its significance. Environ Res. 2019;176: 108528 doi:10.1016/j.envres.2019.108528.
    1. Caspari E, Stern C. The influence of chronic irradiation with gamma rays at low dosages on the mutation rate in drosophila melanogaster. Genetics. 1948;33:75–95. . Accessed December 11, 2019.
    1. Calabrese EJ. Muller’s Nobel lecture on dose-response for ionizing radiation: ideology or science? Arch Toxicol. 2011;85(12):1495–1498.
    1. Jaworowski Z. Radiation hormesis—a remedy for fear. Human Exp Toxicol. 2010;29(4):263–270.
    1. National Academy of Sciences (NAS)/National Research Council (NRC). The biological effects of atomic radiation (BEAR): a report to the public. NAS/NRC, Washington. 1956. Published as, Genetic effects of atomic radiation. Science. 1956;124:1157–1164.
    1. Calabrese EJ. LNTgate: The ideological history of cancer risk assessment. Tox Res App. 2017;1:1–3. doi:10.1177/2397847317694998.
    1. Rowland RE. Radium dial painters: what happened to them? Circa 2000. . Accessed December 11, 2019.
    1. Evans RD. Radium in man. Health Phys. 1974;27:497–510.
    1. Calabrese EJ. X-ray treatment of carbuncles and furuncles (boils): a historical assessment. Hum Exper Toxicol. 2013;32(8):817–827.
    1. Calabrese EJ, Dhawan G. The role of x-rays in the treatment of gas gangrene: a historical assessment. Dose-Response. 2012;10:626–643.
    1. Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013;86:555–570.
    1. Calabrese EJ, Dhawan G. The historical use of radiotherapy in the treatment of sinus infections. Dose-Response. 2013;11:469–479.
    1. Calabrese EJ, Dhawan G. Historical use of x-rays: treatment of inner ear infections and prevention of deafness. Hum Exper Toxicol. 2014;33(5):542–553.
    1. Calabrese EJ, Dhawan G, Kapoor R. Use of X-rays to treat shoulder tendonitis/bursitis: a historical assessment. Arch Toxicol. 2014;88:1503–1517.
    1. Calabrese EJ, Dhawan G, Kapoor R. The use of X-rays in the treatment of bronchial asthma: a historical assessment. Rad Res. 2015;184:180–192.
    1. Calabrese EJ, Dhawan G, Kapoor R. Radiotherapy for pertussis: an historical assessment. Dose-Response. 2017;2017:1–9.
    1. Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose. Hum Exp Toxicol. 2019;38(8):888–898.
    1. Dhawan G, Kapoor R, Dhamija A, Singh R, Monga B, Calabrese EJ. Necrotizing fasciitis: low-dose radiotherapy as a potential adjunct treatment. Dose-Response. 2019;17(3):1–6.
    1. Kelly JF, Dowell DA. Twelve-year review of X-ray therapy of gas gangrene. Radiology. 1941;37:421–439.
    1. National Cancer Institute. Nasopharyngeal radium irradiation (NRI) and cancers: fact sheet. 2003. . Accessed December 11, 2019.
    1. Centers for Disease Control and Prevention. Proceedings of 1995 workshop on the public health response to nasopharyngeal radium irradiation. J Otolaryngology Head Neck Surg. 1996;115:388–446. . Accessed December 11, 2019.
    1. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Brochure. Nasopharyngeal radium irradiation (NRI) 2014. Accessed December 11, 2019.
    1. Proctor DF. The Tonsils and Adenoids in Childhood. Springfield, IL: Thomas; 1960. Chap 2 . Accessed December 11, 2019.
    1. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. New York, NY: Lippincott Williams & Wilkins; 2011.
    1. American Board of Internal Medicine. Choosing Wisely. . Accessed December 11, 2019.
    1. Image Gently Alliance. Alliance for radiation safety in pediatric imaging. Image Gently 2007. . Accessed December 11, 2019.
    1. Billen D. Spontaneous DNA damage and its significance for the “negligible dose” controversy in radiation protection. Rad Res. 1990;124:242–245.
    1. Pollycove M, Feinendegen LE. Radiation-induced versus endogenous DNA damage: possible effects of inducible protective responses in mitigating endogenous damage. Hum Exp Toxicol. 2003;22:290–306.
    1. Sakamoto K, Myojin M, Hosoi Y, et al. Fundamental and clinical studies on cancer control with total or half body irradiation. J Jpn Soc Ther Radiol. 1997;9:161–175.
    1. Welsh JS. Waldenstrom’s macroglobulinemia treated with fractionated low-dose total body irradiation. Case Rep Clin Pract Rev. 2004;5:425–431.
    1. Pollycove M. Radiobiological basis of low-dose irradiation in prevention and therapy of cancer. Dose-Response. 2007;5:26–38.
    1. Cuttler JM, Garzon P, Mitchel REJ, Feinendegen LE, Sakamoto K, Welsh JS. Adjuvant therapy for resected exocrine pancreatic cancer by half-body low-dose irradiation. J Cancer Clin Trials. 2016;1:105 doi:10.4172/jcct.1000105.
    1. Kojima S, Tsukimoto M, Shimura N, Koga H, Murata A, Takara T. Treatment of cancer and inflammation with low-dose ionizing radiation: three case reports. Dose-Response. 2017;15(1):1–7. doi:10.1177/1559325817697531.
    1. Kojima S, Cuttler JM, Shimura N, Koga H, Murata A, Kawashima A. Present and future prospects of radiation therapy using α-emitting nuclides. Dose-Response. 2018;16(1):1–8. doi:10.1177/1559325817747387.
    1. Kojima S, Thukimoto M, Cuttler JM, et al. Recovery from rheumatoid arthritis following 15 months of therapy with low doses of ionizing radiation: a case report. Dose-Response. 2018;16(3):1–7.
    1. Kojima S, Cuttler JM, Inoguchi K, et al. Radon therapy is very promising as a primary or an adjuvant treatment for different types of cancers: 4 case reports. Dose-Response. 2019;17(2):1–9.
    1. Kojima S, Cuttler JM, Shimura N, Koga H, Murata A, Kawashima A. Radon therapy for autoimmune diseases pemphigus and diabetes: 2 case reports. Dose-Response. 2019;17(2):1–8.
    1. Doss M. Low dose radiation adaptive protection to control neurodegenerative diseases. Dose-Response. 2014;12(2):277–287.
    1. Cuttler JM, Moore ER, Hosfeld VD, Nadolski DL. Treatment of Alzheimer disease with CT scans: a case report. Dose-Response. 2016;14(2):1–7.
    1. Cuttler JM, Moore ER, Hosfeld VD, Nadolski DL. Update on a patient with Alzheimer disease treated with CT scans. Dose-Response. 2017;15(1):1–2.
    1. Cuttler JM, Moore ER, Hosfeld VD, Nadolski DL. Second update on a patient with Alzheimer disease treated with CT scans. Dose-Response. 2018;16(1):1–2.
    1. Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017;86:715–748.
    1. Feinendegen LE, Cuttler JM. Biological effects from low doses and dose rates of ionizing radiation: science in the service of protecting humans: a synopsis. Health Phys. 2018;114(6):623–626.
    1. Fliedner TM, Graessle DH, Meineke V, Feinendegen LE. Hemopoietic response to low dose-rates of ionizing radiation shows stem cell tolerance and adaptation. Dose Response. 2012;10(4):644–663.
    1. Cuttler JM. Evidence of a dose threshold for radiation-induced leukemia. Dose-Response. 2018;16(4):1–5.
    1. Cuttler JM. Evidence of dose threshold for radiation-induced leukemia: absorbed dose and uncertainty. Dose-Response. 2019;17(1):1–2.
    1. OECD Nuclear Energy Agency. Chernobyl ten years on: radiological and health impact. 1995. . Accessed December 11, 2019.
    1. Jaworowski Z. Comments by representative of Poland in UNSCEAR on The Chernobyl Forum Report. January 5, 2006 President’s Special Session on Low-Level Radiation and Its Implications for Fukushima Recovery. Chicago, IL: American Nuclear Society; 2012:131–141.
    1. Barabanova AW. Prediction and actual data 30 years after the accident. Presentation at: International Conference on Health Effects of Chernobyl; Obninsk, Russia; May 17-19, 2016.
    1. Taylor LS. Some nonscientific influences on radiation protection standards and practice. The 1980 Sievert Lecture. 5th International Congress of the International Radiation Protection Association. Jerusalem. Health Phys. 1980;39(12):851–874. .
    1. Aisen PS. Editorial: Failure after failure. What next in AD drug development? J Prev Alz Dis. 2019;6(3):150.
    1. Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: Review. JAMA. 2019;322(16):1589–1599.

Source: PubMed

3
Abonnieren